Securities
We're currently building out coverage for Swiss-listed stocks (SIX Exchange). Other markets will follow.

Cosmo N.V.

5y streak
NL0011832936 · COPNSIX · 🇳🇱 NL · Healthcare · Stock

Cosmo N.V. is a Dutch-incorporated specialty pharmaceutical company focused on the development and commercialization of treatments for gastrointestinal diseases, with its primary operations conducted through its Irish subsidiary Cosmo Pharmaceuticals. The company is known for products such as Methylene Blue MMX for colorectal cancer detection and budesonide-based therapies for inflammatory bowel conditions. Cosmo also has a diagnostics and medical devices division and licenses several of its technologies to pharmaceutical partners globally.

Last Dividend

2.10

EUR · 2026-04-24

5Y Growth

+4.14%

CAGR

Frequency

Annual

Years Paid

5

consecutive

Not Cut

4

consecutive yrs

Grown

4

consecutive yrs

Listings

Exchange Ticker Currency
SIX primary
COPN CHF

Annual Dividends

EUR 1.40
2016
EUR 1.50
2017
2018
2019
2020
2021
EUR 0.95
2022
EUR 1.05
2023
EUR 2.00
2024
EUR 2.05
2025
EUR 2.10
2026

Annual dividend per share · 7 years of data

Dividend History

Ex-Date Pay-Date Amount Type
24.04.202611.05.20262.10 EUROrdinary
04.06.202506.06.20252.05 EUROrdinary
10.07.202412.07.20242.00 EUROrdinary
31.05.202302.06.20231.05 EUROrdinary
01.06.202203.06.20220.95 EUROrdinary
29.05.201731.05.20171.50 EUROrdinary
01.09.201615.09.20161.40 EUROrdinary